Novel macromolecule transduction domains and methods for identification and uses thereof

Details for Australian Patent Application No. 2008211854 (hide)

Owner Procell Therapeutics Inc.

Inventors Do, Thi Lan Phuong; Jo, Dae Woong; Lim, Jung Hee; Do, Thi Thuy Nga; Kim, Jin Sook; Song, Jin Kyung; Duong, Minh Tam; Ko, Jae Sun; Park, Kyung Mi

Agent Shelston IP

Pub. Number AU-B-2008211854

PCT Pub. Number WO2008/093982

Priority 60/887,060 29.01.07 US

Filing date 29 January 2008

Wipo publication date 7 August 2008

Acceptance publication date 16 August 2012

International Classifications

C07K 7/04 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/093982 Priority application(s): WO2008/093982

16 August 2012 Application Accepted

  Published as AU-B-2008211854

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008211871-MRI T1 contrasting agent comprising manganese oxide nanoparticle

2008211847-Process for the preparation of (R) -5- (2-aminoethyl) -1- (6, 8 -di fluorochromans -yl ) -1, 3-dihydroimidazole-2-thione